Citation Impact
Citing Papers
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Guidelines for the Prevention of Stroke in Women
2014
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Resistant Hypertension
2008
Significance of angiotensin type 1 receptor blockade: why are angiotensin II receptor blockers different?
1999
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Guidelines for the diagnosis and treatment of chronic heart failure
2001
Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored
2014
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
2012
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
2003 Standout
The Failing Heart — An Engine Out of Fuel
2007 Standout
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials
2013
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
2015
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Guidelines for the Primary Prevention of Stroke
2010
Update on recent clinical trials in congestive heart failure
2000
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension
2011
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
2003 Standout
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Worldwide access to treatment for end-stage kidney disease: a systematic review
2015 Standout
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
2013
Diabetic foot ulcers
2003 Standout
Type 1 diabetes
2013 Standout
Angiotensin II Receptor Blocker-based Therapy in Japanese Elderly, High-risk, Hypertensive Patients
2012
Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors
2002
Direct Comparison of B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in a Large Population of Patients with Chronic and Symptomatic Heart Failure: The Valsartan Heart Failure (Val-HeFT) Data
2006
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
2009 Standout
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
2013
The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT
2004
Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension
2010
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency
2007
Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR‐HF) study: a randomized, placebo‐controlled study of intravenous iron supplementation in patients with and without anaemia
2009
The Hallmarks of Aging
2013 Standout
Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke
2010
Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis
2013
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Biomarkers in Heart Failure
2008 Standout
Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
2012
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes
2008
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches
2011
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Markers of Inflammation and Cardiovascular Disease
2003 Standout
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
2000
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Variable Impact of Combining Fatal and Nonfatal End Points in Heart Failure Trials
2006
Hydrolyzed Infant Formula and Early β-Cell Autoimmunity
2014
Guidelines for the Primary Prevention of Stroke
2014 Standout
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Pathological Ventricular Remodeling
2013
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Iron-Deficiency Anemia
2015 Standout
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension
2015
Blood Pressure Lowering in Type 2 Diabetes
2015
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Management of High Blood Pressure in Blacks
2010
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
2010 Standout
Dermal Neurovascular Dysfunction in Type 2 Diabetes
2001
Anemia in Chronic Heart Failure
2006
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
2018
Works of Allen Hester being referenced
Left Ventricular Systolic and Diastolic Function, Remodelling, and Clinical Outcomes Among Patients with Diabetes Following Myocardial Infarction and the Influence of Direct Renin Inhibition with Aliskiren
2011
Exceptional early blood pressure control rates: The ACCOMPLISH trial
2007
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: A hypertensive population at high cardiovascular risk
2007
Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure
1999
The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
1996
Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes
2010
Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
2008
Anemia and Change in Hemoglobin Over Time Related to Mortality and Morbidity in Patients With Chronic Heart Failure
2005
Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction
2011
C-Reactive Protein in Heart Failure
2005